RJT
EW icon

Raymond James Trust’s Edwards Lifesciences EW Stock Holding History

Raymond James Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.25M Sell
49,249
-4,037
-8% -$293K 0.07% 232
2024
Q2 		$4.92M Sell
53,286
-500
-0.9% -$44.3K 0.12% 164
2024
Q1 		$5.14M Buy
53,786
+1,635
+3% +$137K 0.12% 160
2023
Q4 		$3.98M Buy
52,151
+3,022
+6% +$210K 0.11% 182
2023
Q3 		$3.4M Buy
49,129
+3,621
+8% +$291K 0.1% 182
2023
Q2 		$4.29M Sell
45,508
-550
-1% -$47.8K 0.12% 160
2023
Q1 		$3.81M Buy
46,058
+2,262
+5% +$178K 0.12% 165
2022
Q4 		$3.27M Buy
43,796
+1,163
+3% +$89.6K 0.11% 177
2022
Q3 		$3.52M Sell
42,633
-355
-0.8% -$34.2K 0.13% 154
2022
Q2 		$4.09M Buy
42,988
+1,565
+4% +$162K 0.15% 139
2022
Q1 		$4.88M Buy
41,423
+4,055
+11% +$455K 0.15% 134
2021
Q4 		$4.84M Buy
37,368
+1,747
+5% +$204K 0.14% 140
2021
Q3 		$4.03M Buy
35,621
+339
+1% +$38.7K 0.13% 141
2021
Q2 		$3.65M Sell
35,282
-986
-3% -$92.9K 0.12% 159
2021
Q1 		$3.03M Buy
36,268
+12,786
+54% +$1.08M 0.11% 179
2020
Q4 		$2.14M Buy
23,482
+3,309
+16% +$274K 0.08% 213
2020
Q3 		$1.61M Buy
20,173
+1,368
+7% +$107K 0.07% 233
2020
Q2 		$1.3M Sell
18,805
-770
-4% -$54.7K 0.06% 254
2020
Q1 		$1.23M Sell
19,575
-4,170
-18% -$301K 0.07% 232
2019
Q4 		$1.85M Buy
23,745
+606
+3% +$47.3K 0.09% 200
2019
Q3 		$1.7M Buy
23,139
+678
+3% +$47.6K 0.09% 212
2019
Q2 		$1.38M Sell
22,461
-219
-1% -$13.2K 0.08% 235
2019
Q1 		$1.45M Sell
22,680
-11,910
-34% -$680K 0.08% 213
2018
Q4 		$1.77M Sell
34,590
-2,823
-8% -$143K 0.11% 184
2018
Q3 		$2.17M Buy
37,413
+753
+2% +$36.8K 0.12% 176
2018
Q2 		$1.78M Buy
36,660
+411
+1% +$19.2K 0.11% 193
2018
Q1 		$1.69M Buy
36,249
+3,033
+9% +$132K 0.12% 179
2017
Q4 		$1.25M Buy
33,216
+3,042
+10% +$112K 0.08% 222
2017
Q3 		$1.1M Buy
30,174
+5,808
+24% +$222K 0.08% 227
2017
Q2 		$960K Sell
24,366
-420
-2% -$15.3K 0.07% 249
2017
Q1 		$777K Sell
24,786
-9,108
-27% -$285K 0.06% 283
2016
Q4 		$1.06M Buy
33,894
+2,796
+9% +$90.6K 0.08% 226
2016
Q3 		$1.25M Buy
31,098
+1,467
+5% +$55.2K 0.11% 188
2016
Q2 		$985K Sell
29,631
-513
-2% -$17.6K 0.09% 212
2016
Q1 		$887K Sell
30,144
-600
-2% -$16.6K 0.08% 234
2015
Q4 		$809K Buy
30,744
+5,478
+22% +$142K 0.07% 240
2015
Q3 		$598K Buy
25,266
+5,928
+31% +$143K 0.07% 264
2015
Q2 		$459K Sell
19,338
-12
-0.1% -$271 0.05% 337
2015
Q1 		$459K Sell
19,350
-450
-2% -$10.1K 0.05% 343
2014
Q4 		$421K Hold
19,800
– – 0.05% 371
2014
Q3 		$337K Buy
19,800
+3,000
+18% +$47.4K 0.04% 395
2014
Q2 		$240K Hold
16,800
– – 0.03% 494
2014
Q1 		$208K Buy
+16,800
New +$194K 0.03% 516

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Raymond James Trust's EW Position: Q3 2024 in Review

Raymond James Trust reduced its Edwards Lifesciences (EW) stake by 7.6% in Q3 2024, selling an estimated $293K and leaving 49,249 shares worth $3.25M. The position accounts for 0.07% of the portfolio, ranked #232.

Raymond James Trust first reported a position in EW in Q1 2014 and has held it in 43 quarters since. The position peaked at $5.14M in Q1 2024. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Raymond James Trust held 49,249 shares of Edwards Lifesciences worth $3.25M as of Q3 2024.
  • Raymond James Trust sold 4,037 Edwards Lifesciences shares in Q3 2024, an estimated $293K.
  • Edwards Lifesciences made up 0.07% of Raymond James Trust's portfolio in Q3 2024, its #232 holding.
  • Raymond James Trust first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 43 quarters since.
  • Raymond James Trust's Edwards Lifesciences position peaked at $5.14M in Q1 2024.
  • 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.